Pamela Hinson
Family · Brunswick, GANPI 1780187120
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (45.0%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 36 manufacturers reported payments, led by Amgen at 53.0% of the total. Reporting peaked in 2023 at $7,886 and has fallen 93.1% since, to $546 in 2025. Among family clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 280 payments — averaging $58.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$9K
- Bayer$2K
- AstraZeneca$1K
- Novo Nordisk$589
- AbbVie$425
- Mallinckrodt Hospital Products Inc.$422
- plus $3K from 30 others
What the payments were for
- Consulting fees$1401%
- Speaking & faculty fees$4,48027%
- Travel & lodging$4,21326%
- Food & beverage$7,36545%
- Education$1781%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 41 | $8,680 |
| Bayer | 34 | $2,148 |
| AstraZeneca(2 entities) | 39 | $1,382 |
| Novo Nordisk | 38 | $589 |
| AbbVie | 10 | $425 |
| Mallinckrodt Hospital Products Inc. | 20 | $422 |
| Vifor Pharma, Inc. | 15 | $411 |
| Ardelyx, Inc. | 4 | $378 |
| Paratek Pharmaceuticals, Inc. | 5 | $262 |
| Aurinia Pharma U.S., Inc. | 10 | $236 |
| Otsuka America Pharmaceutical, Inc. | 10 | $218 |
| Medtronic | 2 | $155 |
| Dexcom, Inc. | 3 | $105 |
| Astellas Pharma US Inc | 1 | $100 |
| Lilly USA, LLC | 6 | $99 |
| Fresenius USA Marketing, Inc. | 6 | $99 |
| OPKO Pharmaceuticals, LLC | 4 | $88 |
| Calliditas Therapeutics US Inc. | 3 | $58 |
| Travere Therapeutics, Inc. | 5 | $56 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $45 |
| Abbott | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| ANI Pharmaceuticals, Inc. | 2 | $37 |
| Xeris Pharmaceuticals, Inc. | 2 | $32 |
| Nxstage Medical, Inc. | 1 | $31 |
| Kyowa Kirin, Inc. | 1 | $30 |
| GSK | 2 | $27 |
| Boston Scientific | 1 | $26 |
| Boehringer Ingelheim | 1 | $25 |
| Novartis | 1 | $24 |
| Sanofi | 1 | $23 |
| Insulet Corporation | 1 | $22 |
| Almatica Pharma LLC | 1 | $17 |
| Ultragenyx Pharmaceutical Inc. | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Alnylam Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$16,375 in reported general payments places this provider in the 95th percentile of 6,258 family providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XphozahTenapanor Hcl | 24 | $66,981 |
| OzempicSemaglutide | 40 | $39,367 |
| MounjaroTirzepatide | 20 | $25,828 |
| FarxigaDapagliflozin Propanediol | 17 | $22,191 |
| JanuviaSitagliptin Phosphate | 20 | $22,073 |
| EliquisApixaban | 15 | $13,533 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 12 | $8,328 |
| Sevelamer Carbonate | 12 | $5,198 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 41 | $1,240 |
| Gabapentin | 40 | $553 |
| Losartan Potassium | 62 | $474 |
| Atorvastatin Calcium | 71 | $453 |
| Levothyroxine Sodium | 51 | $376 |
| Valsartan | 24 | $350 |
| Fluticasone Propionate | 33 | $296 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $589 | $39,36740 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $1,382 | $30,51929 claims |
| Lilly USA, LLCMounjaro | $99 | $25,82820 claims |
| ANI Pharmaceuticals, Inc.Valsartan | $37 | $35024 claims |
| Almatica Pharma LLCSertraline Hcl | $17 | $10913 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,258 family providers in Georgia.
Other family in Brunswick
- Allie McAllisterMarietta$299K
- Erin HenryLawrenceville$135K
- Trisha RomanPeachtree City$134K
- Lori ReedMarietta$106K
- Julia BranchCumming$102K
- Hannah BanachWaycross$85K
- Morgan GroothandEvans$81K
- Anna Carolina WrightLilburn$69K
- Jessica FeehanCanton$51K
- Julia ThorneCanton$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.